Andrew Morgan
Description Symonds joins Novartis from Goldman Sachs starting September 1, 2009. Symonds, spent eight years as CFO at AstraZeneca, where his position encompassed Finance, M&A, Strategy, IT, Purchasing, Business Development and Licensing. Before that he was Finance Director at Zeneca and previously was a partner at KPMG. Novartis announced that Jonathan Symonds, currently Managing Director, Investment Banking, at Goldman Sachs joining Novartis as deputy CFO and as CFO effective February 1, 2010, reporting to Raymund Breu, who retire on March 31, 2010 at the age of 65, after 35 years of outstanding service to Novartis. To view the detailed information, you need to SUBSCRIBE with us. |
 |